Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome, Proceedings of the National Academy of Sciences, vol.103, issue.8, pp.2770-2775, 2006. ,
DOI : 10.1073/pnas.0510837103
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proceedings of the National Academy of Sciences, vol.100, issue.5, pp.2610-2615, 2003. ,
DOI : 10.1073/pnas.0337679100
Plasmacytoid Dendritic Cells (Natural Interferon- ??/??-Producing Cells) Accumulate in Cutaneous Lupus Erythematosus Lesions, The American Journal of Pathology, vol.159, issue.1, pp.237-280, 2001. ,
DOI : 10.1016/S0002-9440(10)61689-6
Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray, Genes and Immunity, vol.4, issue.3 ,
DOI : 10.1038/sj.gene.6363966
Activation of the interferon-?? pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease, Arthritis & Rheumatism, vol.19, issue.5, pp.1491-503, 2005. ,
DOI : 10.1002/art.21031
In primary Sj??gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response, Arthritis & Rheumatism, vol.20, issue.8, pp.2240-2245, 2003. ,
DOI : 10.1002/art.11103
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus, Arthritis & Rheumatism, vol.285, issue.1, pp.129-163, 2000. ,
DOI : 10.1002/1529-0131(200001)43:1<129::AID-ANR16>3.0.CO;2-S
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus, Nature Genetics, vol.40, issue.5, pp.550-555, 2006. ,
DOI : 10.1086/302957
Polymorphisms in the Tyrosine Kinase 2 and Interferon Regulatory Factor 5 Genes Are Associated with Systemic Lupus Erythematosus, The American Journal of Human Genetics, vol.76, issue.3, pp.528-565, 2005. ,
DOI : 10.1086/428480
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus, Proceedings of the National Academy of Sciences, vol.104, issue.16, pp.6758-63, 2007. ,
DOI : 10.1073/pnas.0701266104
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group, Annals of the Rheumatic Diseases, vol.61, issue.6, pp.554-562, 2002. ,
DOI : 10.1136/ard.61.6.554
Association of transforming growth factor ?1 and tumor necrosis factor ? polymorphisms with anti-SSB/La antibody secretion in patients with primary Sj???gren's syndrome, Arthritis & Rheumatism, vol.59, issue.2, pp.570-80, 2004. ,
DOI : 10.1002/art.20060
The type I interferon system in systemic lupus erythematosus, Arthritis & Rheumatism, vol.111, issue.2, pp.408-428, 2006. ,
DOI : 10.1002/art.21571
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren s syndrome ,